More patients with IHD achieved blood pressure targets compared to PAD patients (<140/90 mmHg: 67.9% vs. 43.0%; p < 0.001; <130/80 mmHg: 34.1% vs. 15.7%; p < 0.001), as well as LDL cholesterol targets (<70 mg/dL: 53.1% vs. 41.5%; p = 0.033; <55 mg/dL: 26.5% vs. 16.0%; p = 0.025), and diabetes (HbA1c < 7%, with SGLT2i or GLP1-RA: 21.7% vs. 8.8%; p = 0.032) (Table 4, Figure 1). This evidence concerns the gene GLP1R and diabetes mellitus.